Photo byDaniel FrankonUnsplash

23 October 13:00-14:30Umeå Biotech Incubator, Conference room "Skogen"

Photo byDaniel FrankonUnsplash

Insights and experiences from Mucocort

Jean Lycke has been in the Life Science Industry for over 30 years, with extensive experience in everything from production to regulatory affairs, IP, law, and sales.

Jean Lycke, project leader, and the Mucocort team have taken their mouth ulcer patch from concept to product and is now entering clinical trials.

The journey hasn’t been easy, and in this seminar, Jean Lycke shares insights and experiences from different angles of the Mucocort journey. 

Mucocort gets support from Umeå Biotech Incubator. 

The seminar is open to everyone. 

Photo byRiccardo AnnandaleonUnsplash
Photo byOlga GuryanovaonUnsplash

State aid 

Participation fee: This event is sponsored by Umeå Biotech Incubator (UBI) with support from the European Union. There is no actual fee for participating. For delegates from the industry, state-aid/de-minimis will be accounted for corresponding to 150 SEK per person.

State aid & de-minimis: Umeå Biotech Incubator is obliged to account for activities they arrange, and support they provide, directed to specific companies or a group of companies where the receiving companies do not pay market price for the participation. The value of this support is accounted for as state-aid. 

Small amounts of State aid (‘de minimis’ aid) are exempted from State aid control, as they are deemed to have no impact on competition and trade in the internal market of the European Union (EU). 

De minimis aid indeed refers to small amounts of State aid to undertakings (companies) that do not have to be notified to the European Commission by the EU Member States. The maximum amount is € 300,000 for each undertaking over 3 years.

De minimis can also be granted to large companies that are not entitled to larger sums of state-aid under Article 22. Read more on state-aid and de-minimis here:

© MapTiler © OpenStreetMap contributors

Organized by